J. Edward Moreno

New York

Reporter at Sherwood News

Reporter @Sherwood_News. Say hi: [email protected], DM for Signal

Featured in: Favicon

nytimes.com Favicon

uol.com.br Favicon

msn.com

usatoday.com Favicon

thehill.com Favicon

salon.com

seattletimes.com Favicon

azcentral.com Favicon

bostonglobe.com Favicon

upi.com + 117 more

Articles

Are importers front-running pharma tariffs?

1 week ago | sherwood.news | J. Edward Moreno

(Photo by Brian Lawless/PA Images via Getty Images)Pharmaceutical products imported to the US in the first January and February reached $37 billion, compared to $31 billion during the same period last year. Pharmaceutical products rushed into US ports in the first two months of this year as the threat of tariffs on the industry loom. Pharmaceutical products imported to the US in January and February reached $37 billion, compared to $31 billion during the same period last year.
J&J beats analyst earnings estimates, offers upbeat guidance

1 week ago | sherwood.news | J. Edward Moreno

(Photo by Cristina Arias/Cover/Getty Images)The company doesn't think the threat of tariffs will shrink its profits in 2025. Johnson & Johnson rose in early trading after it reported earnings that beat analysts’ estimates and gave upbeat guidance. The company reported an adjusted earnings per share of $2.77, compared to the $2.58 analysts polled by Factset were expecting. It also reported $21.9 billion in sales, compared to the $21.5 billion analysts were penciling in.
Novo Nordisk, Eli Lilly rise after Pfizer scraps obesity pill

1 week ago | sherwood.news | J. Edward Moreno

Pfizer will stop developing a weight-loss pill after it was linked to liver injury in one patient enrolled in a clinical trial, giving a boost to Novo Nordisk and Eli Lilly, which are fighting to keep their place at the center of the weight-loss drug market. Pfizer’s once-daily pill, called danuglipron, won’t advance into the final stage of testing. Pfizer was flat on the news while Novo and Lilly rose in early trading.
A fifth of Uber rides in Austin are via Waymo: Report

1 week ago | sherwood.news | J. Edward Moreno

About a fifth of all Uber rides in Austin in the last week of March were taken using Waymo, the autonomous driving startup owned by Alphabet, according to YipitData stats obtained by Bloomberg. Austin is the only market where Waymo partners with a ride-share app; in Phoenix, San Francisco, and Los Angeles, it operates on its own. The two firms started the partnership last month. Tesla said in January that it plans to launch its own robotaxi service in Austin this June.
Compounding pharmacy says Eli Lilly’s cease and desist letter means “nothing”

1 week ago | sherwood.news | J. Edward Moreno

(Thomas Fuller/Getty Images)Some compounding pharmacies have kept selling GLP-1s that they say are “personalized” or “tailored” for patients’ needs.
Hims & Hers, at a crossroads, wants to be the Netflix of healthcare

1 week ago | sherwood.news | J. Edward Moreno

The generic drug maker started with cheeky ads selling knockoff Viagra. Now it’s trying to fend off big drugmakers and navigate a critical government ruling to defend a high-growth line of revenue. Hims & Hers, the telehealth company best known for selling erectile dysfunction pills, didn’t set out to reinvent the wheel. Like DoorDash for food delivery or Uber and Lyft for taxis, Hims took things that existed already but made them more convenient.
Tariffs, immigration rhetoric are a double-whammy for Modelo maker's business

2 weeks ago | sherwood.news | J. Edward Moreno

The American company that sells popular Mexican imported beers in the US said President Trump's tariff threats and aggressive immigration enforcement are weighing on its business. Constellation Brands, which sells Modelo and Corona, on Wednesday reported a downbeat outlook for the year as tariffs on the aluminum cans that encase its Mexican beers are set to take effect and its biggest consumer, Hispanics living in the US, are pulling their purse strings.
Pharma stocks sink on threats that they won’t be spared from tariffs much longer

2 weeks ago | sherwood.news | J. Edward Moreno

(Frederick Florin/Getty Images)President Trump said he would impose tariffs on pharmaceuticals, then he didn’t, and now he said he will. Investors are queasy. Pharmaceutical stocks are dipping after President Trump suggested they won’t be spared by tariffs for much longer. Drugmakers were spared from the first round of tariffs that went into effect on Wednesday, despite Trump consistently saying the industry was a priority.
Amazon cancels some inventory orders from China, looks at investing in US warehousing

2 weeks ago | sherwood.news | J. Edward Moreno

Amazon canceled some of its inventory orders coming from China on Wednesday as the Trump administration’s 104% tariffs on the country took effect, according to documents seen by Bloomberg. The online retail giant canceled orders for beach chairs, scooters, and air conditioners. The US imported nearly $440 billion worth of goods from China in 2024, including most of certain consumer goods like vacuums and baby carriages.
BofA: Cigarettes and Coca-Cola tend to hold up during recessions

2 weeks ago | sherwood.news | J. Edward Moreno

If the US does spiral into a self-induced recession, as economists are increasingly predicting, history shows consumer staples may be one of the safest places to invest, according to Bank of America analysts. Some of the companies it recommends are Zyn maker Philip Morris International, sugary drink staple Coca-Cola, and condiment and spice seller McCormick. Those industries have outperformed in most recessions, with the exception of COVID-19.